Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu).

Antimicrobial Agents and Chemotherapy
S R MeshnickY Yuthavong

Abstract

Artemisinin is an important new antimalarial agent containing a bridged endoperoxide. The in vitro antimalarial activity of an artemisinin derivative, arteether, is antagonized by two iron chelators, pyridoxal benzoylhydrazone and 1,2-dimethyl-3-hydroxypyrid-4-one. Similarly, the acute toxicity of artemisinin in mice is antagonized by another chelator, deferoxamine-hydroxyethylstarch. A combination of artemisinin and hemin oxidizes erythrocyte membrane thiols in vitro, and this oxidation is also inhibited by an iron chelator. Thus, iron plays a role in the mechanisms of action and toxicity of artemisinin. The combination of artemisinin and hemin also decreases erythrocyte deformability. Iron probably catalyzes the generation of free radicals from artemisinin since alpha-tocopherol antagonizes the thiol-oxidizing activity of artemisinin and since a spin-trapped free radical signal can be seen by electron paramagnetic resonance only when artemisinin is incubated in the presence of iron.

References

Jan 10, 1977·Biochemical and Biophysical Research Communications·R A Floyd, L M Soong
Dec 1, 1979·Antimicrobial Agents and Chemotherapy·R E DesjardinsJ D Chulay
Feb 1, 1978·The Journal of Infectious Diseases·M C Berenbaum
Apr 25, 1992·Biochemical Pharmacology·F ZhangS R Meshnick
Aug 1, 1990·British Journal of Haematology·M D ScottS R Meshnick
Dec 1, 1991·Molecular and Biochemical Parasitology·S R MeshnickH Z Pan
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D E GoldbergG B Henderson
Jan 1, 1990·Free Radical Biology & Medicine·E BaysalA Stern
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·P E HallawayB E Hedlund
Sep 1, 1988·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·G S MarksC A James
Jan 1, 1988·Transactions of the Royal Society of Tropical Medicine and Hygiene·E StahelM Gentilini
Mar 1, 1988·Journal of Medicinal Chemistry·A BrossiW Peters
Jul 1, 1988·The Journal of Experimental Medicine·C Hershko, T E Peto
Oct 1, 1986·Annals of Tropical Medicine and Parasitology·W PetersD C Warhurst
Jan 1, 1987·Transactions of the Royal Society of Tropical Medicine and Hygiene·S R Krungkrai, Y Yuthavong
Jan 1, 1986·Zeitschrift Für Parasitenkunde·G Fritsch, A Jung
Sep 1, 1982·The American Journal of Tropical Medicine and Hygiene·C Raventos-SuarezR L Nagel
Jan 1, 1963·Archives of Biochemistry and Biophysics·J T DODGED J HANAHAN

❮ Previous
Next ❯

Citations

Aug 1, 1996·Pharmacy World & Science : PWS·N S PostmaJ Zuidema
Aug 5, 1994·Pharmacy World & Science : PWS·H J WoerdenbagC B Lugt
Mar 26, 2011·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Gundula Min-Oo, Philippe Gros
Jun 1, 1994·Transactions of the Royal Society of Tropical Medicine and Hygiene·S R Meshnick
Oct 1, 1994·Molecular and Biochemical Parasitology·W AsawamahasakdaS R Meshnick
Jan 1, 1994·Molecular and Biochemical Parasitology·Y L HongS R Meshnick
Feb 1, 1996·Parasitology Today·S R MeshnickW Peters
Jun 1, 1996·General Pharmacology·S Kamchonwongpaisan, S R Meshnick
May 10, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Thomas Efferth
Nov 19, 2002·International Journal for Parasitology·Steven R Meshnick
Mar 31, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·S XiaoM Tanner
Jun 19, 1998·Pharmacology, Biochemistry, and Behavior·R F GenoveseT G Brewer
Apr 24, 2001·Pharmacology & Therapeutics·P Olliaro
Apr 6, 1999·Pharmacology & Therapeutics·P L Olliaro, Y Yuthavong
Dec 20, 1996·Molecular and Biochemical Parasitology·P J Rosenthal, S R Meshnick
Feb 1, 1997·General Pharmacology·G J FrayhaJ Savel
Mar 20, 2003·Journal of Pharmaceutical and Biomedical Analysis·M Gabriëls, J Plaizier-Vercammen
Jan 1, 1997·Free Radical Biology & Medicine·P A Berman, P A Adams
Nov 24, 1999·Free Radical Biology & Medicine·L FlohéP Steinert
Apr 5, 2001·Trends in Parasitology·P L OlliaroY Yuthavong
Jan 1, 1993·Parasitology·O A Levander, A L Ager
Sep 5, 2013·The Journal of Antimicrobial Chemotherapy·Alyssa FlobinusNathalie Schnepf
Feb 18, 1998·The Journal of Pharmacy and Pharmacology·A C BeekmanH V Wikström
Aug 1, 1994·Antimicrobial Agents and Chemotherapy·W AsawamahasakdaS R Meshnick
May 17, 2001·Antimicrobial Agents and Chemotherapy·B PradinesD Parzy
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Ulrike SponerWalther H Wernsdorfer
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Steven R Meshnick
Jun 19, 2013·Chinese Journal of Integrative Medicine·Shokoofe NooriVida Farsam
Oct 23, 2013·Antimicrobial Agents and Chemotherapy·Philipp P HenrichDavid A Fidock
Sep 28, 2005·Expert Opinion on Therapeutic Targets·Henry LaiNarendra P Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.